Clearline Capital LP Q2 2023 Filing

Filed August 15, 2023

Portfolio Value

$1.7T

Holdings

114

Report Date

Q2 2023

Filing Type

13F-HR

All Holdings (114 positions)

#StockSharesValue% PortfolioType
101
LNSRLENSAR INC
116,013$493.1M0.03%
102
LYRALYRA THERAPEUTICS INC
119,128$489.6M0.03%
103
SPRYARS PHARMACEUTICALS INC
61,102$409.4M0.02%
104
CGNTCOGNYTE SOFTWARE LTD
63,873$389.0M0.02%
105
QSIQUANTUM SI INC
211,900$379.3M0.02%
106
INUVGBPINUVO INC
1,542,607$342.5M0.02%
107
CTMXCYTOMX THERAPEUTICS INC
196,583$338.1M0.02%
108
ORGNWORIGIN MATERIALS INC
395,297$292.5M0.02%
109
NERDY INC
510,400$279.7M0.02%
110
PAYOPAYONEER GLOBAL INC
53,522$257.4M0.01%
111
EX9EXELIXIS INC
12,939$247.3M0.01%
112
VINCERX PHARMA INC
98,916$128.6M0.01%
113
GDEVGDEV INC
338,196$40.6M0.00%
114
NUVB/WSNUVATION BIO INC
33,271$5.5M0.00%
PreviousPage 2 of 2